Astrana Health Inc (ASTH)

Currency in USD
23.08
-0.36(-1.54%)
Real-time Data·
ASTH Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 14 days
Fair Value
Day's Range
22.9723.43
52 wk Range
22.5863.20
Key Statistics
Prev. Close
23.44
Open
23.19
Day's Range
22.97-23.43
52 wk Range
22.58-63.2
Volume
15.7K
Average Volume (3m)
273.42K
1-Year Change
-54.25%
Book Value / Share
14.87
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASTH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
47.44
Upside
+105.57%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Astrana Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Astrana Health Inc Company Profile

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1994 and is headquartered in Alhambra, California.

Astrana Health Inc Earnings Call Summary for Q1/2025

  • Astrana Health missed Q1 2025 forecasts with EPS of $0.14 vs $0.30 expected and revenue of $620.4M vs $628.11M projected
  • Stock fell 3.96% after-hours to $32.11 despite 53% year-over-year revenue growth and 4.01% gain in regular trading
  • Q2 2025 guidance: $615M-$665M revenue, $45M-$50M adjusted EBITDA; long-term goal of $350M adjusted EBITDA by 2027
  • Strategic expansions into Nevada and Texas underway; integration of recent acquisitions key to growth strategy
  • Analysts forecast FY2025 EPS of $1.48; stock viewed as undervalued despite high P/E ratio of 36.7x
Last Updated: 08/05/2025, 23:44
Read Full Transcript

Compare ASTH to Peers and Sector

Metrics to compare
ASTH
Peers
Sector
Relationship
P/E Ratio
33.4x−0.4x−0.5x
PEG Ratio
−0.740.000.00
Price/Book
1.6x1.1x2.6x
Price / LTM Sales
0.5x1.1x3.2x
Upside (Analyst Target)
97.2%42.4%41.9%
Fair Value Upside
Unlock24.7%4.3%Unlock

Analyst Ratings

8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 47.44
(+105.57% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
0.14 / 0.30
Revenue / Forecast
620.40M / 628.11M
EPS Revisions
Last 90 days

ASTH Income Statement

People Also Watch

14.66
DXC
-1.15%
28.52
CNC
-3.06%
16.720
ZETA
+0.97%
30.38
YOU
-1.38%
60.80
MP
-0.56%

FAQ

What Stock Exchange Does Astrana Health Trade On?

Astrana Health is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Astrana Health?

The stock symbol for Astrana Health is "ASTH."

What Is the Astrana Health Market Cap?

As of today, Astrana Health market cap is 1.15B.

What Is Astrana Health's Earnings Per Share (TTM)?

The Astrana Health EPS (TTM) is 0.73.

When Is the Next Astrana Health Earnings Date?

Astrana Health will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is ASTH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Astrana Health Stock Split?

Astrana Health has split 1 times.

How Many Employees Does Astrana Health Have?

Astrana Health has 1900 employees.

What is the current trading status of Astrana Health (ASTH)?

As of 24 Jul 2025, Astrana Health (ASTH) is trading at a price of 23.08, with a previous close of 23.44. The stock has fluctuated within a day range of 22.97 to 23.43, while its 52-week range spans from 22.58 to 63.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.